Johnson & Johnson Announces $55 Billion Investment in Domestic Manufacturing, Research

Johnson & Johnson will invest $55 billion in U.S. facilities over four years, starting with a $2 billion plant in North Carolina.

A Johnson & Johnson banner is displayed on the front of the New York Stock Exchange (NYSE) in New York City, on Dec. 5, 2023. Brendan McDermid/Reuters

Johnson & Johnson announced plans Friday to invest more than $55 billion in manufacturing, research, and technology across the United States during the next four years.

The investment marks a 25 percent increase over the company’s previous four-year spending, the company said in the March 21 announcement. It comes amid growing pressure on pharmaceutical companies to expand domestic production due to potential tariffs on drug imports.